Can American Medical Devices be Sold in Europe?

Yes, American medical devices can be sold in Europe, but you need more than FDA approval. You must obtain CE marking under the Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR), appoint an EU Authorized Representative, and comply with European regulatory frameworks. The process involves technical documentation, conformity assessment, and registration in European databases. Understanding these requirements helps you plan your European market entry strategy effectively.

What do American manufacturers need to sell medical devices in Europe?

American manufacturers need CE marking certification, an EU Authorized Representative, and compliance with MDR or IVDR regulations to sell medical devices in Europe. Your FDA approval doesn’t transfer to European markets, so you’ll need to prepare technical documentation, undergo conformity assessment, and register your devices in the European database for medical devices (EUDAMED).

The European regulatory system operates differently from the US approach. Key requirements include:

• Device classification according to European rules – Your device classification may differ from your FDA classification, affecting your regulatory pathway and requirements
• Notified Body involvement for higher-risk devices – Class IIa, IIb, and III devices require assessment by an independent organization that verifies conformity with European regulations
• Self-certification option for lower-risk devices – Class I devices may qualify for self-certification, though comprehensive technical documentation remains mandatory
• Comprehensive technical file preparation – You must compile risk analysis, clinical evaluation, design verification, and manufacturing information
• Post-market surveillance systems – European regulations emphasize ongoing vigilance reporting and monitoring throughout your device’s lifecycle
• European-compliant labeling and identification – Your labeling, instructions for use, and unique device identification must meet European standards before market placement

These requirements create a regulatory framework that differs fundamentally from the FDA system, requiring American manufacturers to approach European market entry as a distinct regulatory process rather than an extension of their US approval. Success depends on understanding these differences early and building appropriate documentation and quality systems that satisfy European expectations from the outset.

How does the CE marking process work for US medical device companies?

The CE marking process starts with device classification and selecting your conformity assessment route. You’ll prepare a technical file, undergo assessment (either self-certification or through a Notified Body), create a Declaration of Conformity, and affix the CE mark to your device and packaging. The timeline varies from a few months for low-risk devices to over a year for high-risk products requiring Notified Body review.

The process follows these key stages:

• Classification and pathway selection – Class I devices often qualify for self-certification, while Class IIa, IIb, and III devices require Notified Body involvement, determining your timeline and costs
• Technical documentation preparation – You’ll compile comprehensive files demonstrating design, manufacturing processes, and clinical evidence according to European standards
• Notified Body assessment (if required) – The Notified Body reviews your submissions, conducts facility audits, and establishes ongoing surveillance requirements
• Clinical evaluation report development – European regulations require demonstration of safety and performance through clinical data, which can leverage existing FDA submission data when properly formatted
• Declaration of Conformity issuance – Once assessment is complete, you formally declare your device meets all applicable European requirements
• EUDAMED registration – Before commercialization, you must register your device in the European database, making information accessible to authorities and healthcare professionals

Many American manufacturers underestimate the documentation depth required, particularly for clinical evaluation reports that must present evidence according to European standards rather than simply referencing FDA submissions. The assessment process is iterative, often involving multiple rounds of questions and clarifications with Notified Bodies, making realistic timeline planning essential for successful market entry.

What’s the difference between FDA approval and European CE marking?

FDA approval uses a centralized pre-market review system, while CE marking relies on a decentralized approach with post-market emphasis. The FDA conducts direct product review and approval, whereas European conformity assessment involves manufacturer declarations and Notified Body verification. Clinical evidence requirements differ significantly, with Europe often accepting broader types of clinical data than the FDA’s stringent pre-market clinical trial requirements.

The fundamental differences between these systems include:

• Regulatory authority structure – The FDA maintains centralized control over device review and approval, while European regulation distributes responsibilities among manufacturers, Authorized Representatives, importers, and national competent authorities across member states
• Pre-market versus post-market focus – FDA emphasizes rigorous pre-market review before authorization, whereas European regulations balance initial conformity assessment with extensive post-market surveillance obligations
• Clinical evidence standards – Europe accepts clinical data from literature, post-market studies, and equivalent device data more readily than the FDA, which often requires prospective clinical trials for higher-risk devices
• Ongoing compliance responsibility – European regulations place continuous documentation, surveillance, and reporting obligations on manufacturers throughout the product lifecycle, requiring active compliance management rather than periodic FDA interactions
• Incident reporting systems – The European vigilance system requires prompt reporting of serious incidents and field safety corrective actions through your Authorized Representative, operating differently from FDA’s MedWatch system
• Inspection and enforcement approach – FDA conducts facility inspections directly, while European oversight involves Notified Body surveillance audits and national competent authority inspections triggered by specific concerns

These systemic differences mean American manufacturers cannot simply transfer their FDA compliance approach to Europe. European regulations demand greater manufacturer responsibility for ongoing compliance, continuous technical documentation updates, and proactive post-market surveillance. This shift from FDA’s centralized oversight model to Europe’s manufacturer-responsibility framework requires different internal systems, processes, and often specialized regulatory support to navigate effectively.

Do you need a European representative to sell medical devices in the EU?

Yes, non-EU manufacturers must appoint an EU Authorized Representative to legally place medical devices on the European market. This requirement is mandatory under MDR and IVDR regulations. Your Authorized Representative serves as your legal contact point for European authorities, maintains regulatory documentation, and assists with incident reporting and corrective actions.

Your Authorized Representative’s responsibilities include verifying device compliance before market placement, ensuring proper registration in EUDAMED, maintaining technical documentation accessibility, and coordinating with competent authorities during inspections or investigations. They must be clearly identified on your device labeling and instructions for use, making this relationship visible to end users and authorities.

Selecting an independent regulatory provider as your Authorized Representative offers advantages over appointing a commercial partner like your distributor. An independent representative focuses solely on regulatory compliance without competing commercial interests. This becomes particularly important when you work with multiple distributors across Europe, as designating one distributor as your representative may create commercial conflicts with others. The right representative provides regulatory expertise, maintains compliance systems, and supports your long-term European market presence.

Understanding US to EU medical device compliance requirements helps you plan resources, timelines, and partnerships effectively. European medical device regulations create obligations throughout your product lifecycle, making experienced regulatory support valuable for American manufacturers entering these markets.

How MedEnvoy Global helps American manufacturers sell medical devices in Europe

MedEnvoy Global provides comprehensive regulatory support for US medical device and IVD manufacturers entering European markets. Our services address the complete spectrum of European compliance requirements:

• EU Authorized Representative services – We serve as your mandatory legal representative, maintaining regulatory documentation, coordinating with competent authorities, and ensuring ongoing compliance with MDR and IVDR requirements
• CE marking consultation – Our regulatory experts guide you through device classification, conformity assessment pathway selection, technical file preparation, and Notified Body coordination
• EUDAMED registration support – We manage your device registration in the European database, ensuring accurate and timely submission of required information
• Post-market surveillance systems – We establish vigilance reporting processes, manage incident investigations, and coordinate field safety corrective actions across European markets
• Strategic regulatory planning – We help you understand timeline expectations, resource requirements, and regulatory pathway options tailored to your specific device portfolio

Our independent status ensures your regulatory compliance remains separate from commercial relationships, allowing you to work with multiple distributors without conflicts. We focus exclusively on regulatory excellence, giving you confidence that your European market presence rests on solid compliance foundations. Contact MedEnvoy Global today to discuss how we can support your European market entry strategy and serve as your trusted EU Authorized Representative.

Related Articles

• Who Can Help Me Sell Medical Devices in Europe?
• What Testing Is Required for Mexico Medical Device Registration?
• What Are Class I, II, and III Devices in Mexico?
• How Do I Enter the Italian Medical Device Market?
• When Should Medical Device Companies Consider Switching Representation Providers?